These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30363665)

  • 1. Institutional Incidence of Severe tPA-Induced Angioedema in Ischemic Cerebral Vascular Accidents.
    Sczepanski M; Bozyk P
    Crit Care Res Pract; 2018; 2018():9360918. PubMed ID: 30363665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orolingual Angioedema After Tissue Plasminogen Activator Administration in Patients Taking Angiotensin-Converting Enzyme Inhibitors.
    Burd M; McPheeters C; Scherrer LA
    Adv Emerg Nurs J; 2019; 41(3):204-214. PubMed ID: 31356244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, predictors and clinical characteristics of orolingual angio-oedema complicating thrombolysis with tissue plasminogen activator for ischaemic stroke.
    Hurford R; Rezvani S; Kreimei M; Herbert A; Vail A; Parry-Jones AR; Douglass C; Molloy J; Alachkar H; Tyrrell PJ; Smith CJ
    J Neurol Neurosurg Psychiatry; 2015 May; 86(5):520-3. PubMed ID: 25016564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Approach to the Treatment of Orolingual Angioedema After Tissue Plasminogen Activator Administration.
    Pahs L; Droege C; Kneale H; Pancioli A
    Ann Emerg Med; 2016 Sep; 68(3):345-8. PubMed ID: 27174372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angioedema Secondary to tPA Use in Acute Ischemic Stroke Patient with Hypertension: A Case Report.
    Kim C; Hladik A
    Clin Pract Cases Emerg Med; 2021 May; 5(2):159-162. PubMed ID: 34436994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue Plasminogen Activator-Induced Angioedema Involving a Posterior Cerebral Artery Infarct: A Case Presentation.
    Duymun S; Reddy V; Bentley E; Bose-Kolanu A
    Am J Case Rep; 2021 Jan; 22():e927137. PubMed ID: 33441533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke.
    Engelter ST; Fluri F; Buitrago-Téllez C; Marsch S; Steck AJ; Rüegg S; Lyrer PA
    J Neurol; 2005 Oct; 252(10):1167-70. PubMed ID: 16184341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Audit report and systematic review of orolingual angioedema in post-acute stroke thrombolysis.
    Lekoubou A; Philippeau F; Derex L; Olaru A; Gouttard M; Vieillart A; Kengne AP
    Neurol Res; 2014 Jul; 36(7):687-94. PubMed ID: 24620962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angiotensin-converting enzyme inhibitor use.
    Lin SY; Tang SC; Tsai LK; Yeh SJ; Hsiao YJ; Chen YW; Chen KH; Yip BS; Shen LJ; Wu FL; Jeng JS
    Eur J Neurol; 2014 Oct; 21(10):1285-91. PubMed ID: 24909847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angioedema: A Life-threatening Complication of Tissue Plasminogen Activator.
    Khalid M; Kanaa M; Alkawaleet Y; Ayub MT
    Cureus; 2018 Mar; 10(3):e2392. PubMed ID: 29850387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of recurrent angiotensin converting enzyme inhibitor-induced angioedema.
    Roberts DS; Mahoney EJ; Hutchinson CT; Aliphas A; Grundfast KM
    Laryngoscope; 2008 Dec; 118(12):2115-20. PubMed ID: 19029862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ipsilateral Orolingual Angioedema Following Alteplase Administration for the Treatment of Suspected Acute Ischemic Stroke.
    Tolu-Akinnawo O; Ogwu OI; Nnamani I; Talabi T
    Cureus; 2023 May; 15(5):e38714. PubMed ID: 37168409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke.
    Hill MD; Lye T; Moss H; Barber PA; Demchuk AM; Newcommon NJ; Green TL; Kenney C; Cole-Haskayne A; Buchan AM
    Neurology; 2003 May; 60(9):1525-7. PubMed ID: 12743244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Case Report of Unilateral Orolingual Angioedema Secondary to Alteplase Administration.
    Harris D; Harter D
    Cureus; 2018 Jun; 10(6):e2869. PubMed ID: 30148021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angioedema from recombinant TPA administration: case report and pathophysiology review.
    Foster-Goldman A; McCarthy D
    Am J Ther; 2013; 20(6):691-3. PubMed ID: 24247033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angioedema after tPA: what neurointensivists should know.
    Fugate JE; Kalimullah EA; Wijdicks EF
    Neurocrit Care; 2012 Jun; 16(3):440-3. PubMed ID: 22311232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icatibant in angiotensin-converting enzyme (ACE) inhibitor-associated angioedema.
    Fok JS; Katelaris CH; Brown AF; Smith WB
    Intern Med J; 2015 Aug; 45(8):821-7. PubMed ID: 25944565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of orolingual angioedema after intravenous thrombolysis for stroke.
    Censori B; Partziguian T; Bonito V; Sgarzi M; Riva R; Alimonti D; Agazzi E; Vedovello M; Frigeni B; Venturelli E; La Gioia S; Barcella V; Daleffe L; Longhi L; Ferri F; Cosentini R; Rottoli MR
    Neurol Sci; 2018 Nov; 39(11):1877-1879. PubMed ID: 30084073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icatibant as a Potential Treatment of Life-Threatening Alteplase-Induced Angioedema.
    Cheong E; Dodd L; Smith W; Kleinig T
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):e36-e37. PubMed ID: 29097062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin converting enzyme inhibitor-related angioedema: onset, presentation, and management.
    Chan NJ; Soliman AM
    Ann Otol Rhinol Laryngol; 2015 Feb; 124(2):89-96. PubMed ID: 25059449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.